23 Stock Top Picks and 5 ETF (Feb 01-07)
This week there were 23 Top Picks and 5 ETF in a wide range of industries: Consumer, Financials, Industrials, Technology and ETF.
Here are this week’s Top Picks as selected by: Bruce Campbell, Chris Stuchberr, John O´Connell, Hap (Robert) Sn, Gerard Ferguson, Colin Stewart, Gordon Reid, Cameron Hurst, Terry Shaunessy and David Burrows.
A safer reopening bet than AMC in light of Merck announcing an anti-Covid pill today. It got crushed recently, but he sees a lot more upside in a post-Covid world.
(A Top Pick Sep 14/20, Up 32%) Medical devices are an important place to be. Good acquisition right before the pandemic. Demographic play. Pandemic backlog should ease and improve revenues. Good opportunity globally for next few years.
Holds it in high regard. Divested and modernized. Expansion into non-meat protein. Earnings are cyclically depressed. Not a barn burner of a growth stock. GDP-esque growth rate. Put in your RRSP. Will do well in the long-term.
(A Top Pick Sep 07/21, Down 5.3%)Stockchase Research Editor: Michael O'Reilly Our recently reiterated PAST TOP PICK with LEN has triggered its stop at $96. To remain disciplined, we recommend covering the position at this time. We will look for better opportunities.
(A Top Pick Dec 08/20, Up 30.2%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with HD is progressing well. We now recommend trailing the stop (from $230) to $315. If triggered, this would all but guarantee a net investment return of 20%.
We've chosen TD from the group, based on the historical pattern of the last one now, will later be first. TD has underperformed its peers so far in 2021. Through the first three calendar quarters, TD has gained 17%, while top dog, National Bank, has run twice as far. Actually, this isn't completely accurate; Bank…
Very fine company. One of the best property and casualty companies in the world. Relatively resilient, defensive business model. Long-term, he recommends it. But for short and medium performance, we're exiting a recession, so it makes sense to put more capital into cyclicals.
Prem Watsa engages in market timing, unlike Warren Buffett. Fairfax is a black box as to what it owns. Challenging business. Stuck in the mud for a while. If you want too look at good capital allocators in the P&C business, look at BRK.B, which he owns.
Good momentum. Basket of commercial, residential, storage, and so on. Issue is the expensive valuation. Another way to play it is to look at the US homebuilders, such as ITB, his preference, which also has a home renovation component. Supply/demand dynamics speak to years and years of home building.
Well loved and well owned. Dividend yield doesn't excite him. Better yields in the sector with similar growth prospects, especially with changing dynamics of retail and office. Steady, stable, but not a lot of growth. Nothing wrong with a long-term hold.
Operational gains have seen diminishing returns. Multiple expansion has kept the stock going. Does the multiple expansion continue, are there more operational efficiencies? Both are ambiguous. That's why they tried to acquire KCU. Slowdown in durable goods, fuel cost inflation, labour price inflation. Economy may slow in the next 12-18 months. Great long-term company. If…
She likes their near- and long-term prospects. WSP shares have done well in the past year. They made key acquisitions in the environmental space. Good balance sheet and strong ESG score. She trimmed her position in recent months, but she still likes this. It's a well-run company in a good business.
RTX is half-defence, half-aerospace whereas peers operate in one of the other. Therefore, this mix offers stable cash profile and can operate counter-cyclically. Can still buyback shares. Cost structure changes will raise earnings growth as well as a rebound in air traffic. It's far less cyclical than competitors. (Analysts’ price target is $101.56)
CN vs. CP He sold CNR earlier this year over high valuation. Both enjoy an oligopoly. Another concern is growth for both rails. Exit when the PE gets too stretch. Both were so desperate for growth that they battled over KSU. He prefers CP, though both are well run, though both PEs are rich. He'd…
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. Recovery pains are expected but there are higher prices and pent up demand that will be tailwinds for Air Canada. Planes are becoming full and prices are up. A decent hold with a 2 year horizon at least. Unlock Premium - Try 5i Free
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. Could deliver good growth although it is more in the cyclical business. Business is solid and the stock has hit more investor’s radar. 3 year + timeframe. Unlock Premium - Try 5i Free
Last year they fended off a challenge from an activist investor. Its platform enables remote work, so share soared during Covid. But then earlier this year, the activist threatened to take it over. Instead, in April, Box struck a deal with another investor, KKR, for a $500 million investment to mostly use to buyback shares.…
(A Top Pick Oct 14/20, Up 76%) Great play on online advertising and search. YouTube is doing well, cloud business is growing. Well positioned. Digital advertising will continue to grow. She recently bought on the recent pullback. You could start building a position here.
Some of their businesses are impacted by the pandemic. They were expecting a turnaround over the last six months. He would hang on. They have world-leading wireless technology. If it was sold tomorrow, it would fetch two to three times what it trades at.
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. The growth story still remains intact and 5i would continue to hold for the long term. If you want to trim to secure some cash, this could make sense. The supply chain focus should remain interesting, considering issues at this time in this domain. Unlock Premium - Try…
He gets a lot of questions about this and avoids it. He doesn't know how they get around these regulatory pressures. He prefers Google in the online ad space.
King of incident reporting in digital workflows. The next Salesforce. Beat on all metrics. Buy some here, and add some down at $560 and 540. 12-month price target of $660. No dividend. (Analysts’ price target is $654.77)
Great business model. Don't sell. A payment system, not a credit card company. Takes on no risk. Pandemic has encouraged people to use less cash. Good organic growth globally. Going into the buy now-pay later business. Travel will improve and they'll do well.
Great. A core holding. Low cost, pure beta play. Bullish on EM. They've underperformed for the last 11 years, and they're set for a long period of outperformance. The issue is that it's still 40% tech, and he's moving away from tech. Look at DEM instead, as it overweights EM companies that have higher dividends…
Happy to own this, outperforming XLV, for instance. It's diversified. ZUH is another option, because it covers pharmas, hospital management and other areas. IHI, as a hospital provider, is pretty good.
Not yet. Investors can re-balance their portfolios. If you aimed for one percentage of equities and another for bonds, you can move money to maintain that balance. That is one of the most prudent things people can do. The bottoms are not in yet.
(A Top Pick Jan 07/19, Up 14%) They are one of the lead orders on this. There was a technical issue where it was listed on the TSX and NEO. The fund refused to list it on the TSX. It doesn't have good liquidity due to this and so they gave it up.
Use this list wisely to identify buying opportunities.
Happy trading !!!